1. OP0048 Romosozumab rapidly reduces clinical vertebral fracture incidence: results from the frame study. (15th June 2017) Authors: Geusens, P; Oates, M; Miyauchi, A; Adachi, J; Lazaretti-Castro, M; Ebeling, PR; Nino, CA Perez; Milmont, CJ; Grauer, A; Libanati, C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0050 The treatment gap after fracture in osteoporosis patients in sweden. (15th June 2017) Authors: Spångéus, A; Åkesson, K; Ljunggren, Ö; Banefelt, J; Karlsson, L; Ortsäter, G; Libanati, C; Toth, E; Ström, O Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Relationship Between Bone Mineral Density T‐Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment. (29th May 2019) Authors: Ferrari, S; Libanati, C; Lin, Celia Jow Fang; Brown, JP; Cosman, F; Czerwiński, E; de Gregόrio, LH; Malouf‐Sierra, J; Reginster, J‐Y; Wang, A; Wagman, RB; Lewiecki, EM Journal: Journal of bone and mineral research Issue: Volume 34:Number 6(2019) Page Start: 1033 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗